BSE Live
Nov 07, 15:02Prev. Close
3114.90
Open Price
3111.20
Bid Price (Qty.)
3100.10 (2)
Offer Price (Qty.)
3103.70 (8)
NSE Live
Nov 07, 15:02Prev. Close
3108.00
Open Price
3108.00
Bid Price (Qty.)
3101.00 (2)
Offer Price (Qty.)
3102.60 (5)
| Key Financial Ratios of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 27.09 | 23.74 | 20.54 | 18.76 | 15.31 | |
| Diluted EPS (Rs.) | 27.04 | 23.69 | 20.52 | 18.69 | 15.20 | |
| Cash EPS (Rs.) | 34.94 | 27.79 | 23.92 | 21.54 | 19.08 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 121.94 | 111.69 | 93.18 | 70.60 | 57.88 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 121.94 | 111.69 | 93.18 | 70.60 | 57.88 | |
| Dividend / Share(Rs.) | 12.00 | 6.00 | 4.50 | 3.00 | 2.45 | |
| Revenue from Operations/Share (Rs.) | 152.81 | 139.77 | 122.89 | 106.17 | 92.58 | |
| PBDIT/Share (Rs.) | 46.24 | 39.51 | 34.51 | 31.11 | 27.12 | |
| PBIT/Share (Rs.) | 38.08 | 35.17 | 30.79 | 27.92 | 23.25 | |
| PBT/Share (Rs.) | 36.32 | 35.08 | 30.69 | 27.84 | 23.19 | |
| Net Profit/Share (Rs.) | 26.78 | 23.45 | 20.19 | 18.36 | 15.21 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 30.26 | 28.26 | 28.08 | 29.30 | 29.29 | |
| PBIT Margin (%) | 24.92 | 25.16 | 25.05 | 26.30 | 25.11 | |
| PBT Margin (%) | 23.76 | 25.09 | 24.97 | 26.22 | 25.05 | |
| Net Profit Margin (%) | 17.52 | 16.77 | 16.43 | 17.29 | 16.42 | |
| Return on Networth / Equity (%) | 21.96 | 20.99 | 21.66 | 26.00 | 26.27 | |
| Return on Capital Employed (%) | 28.67 | 31.44 | 32.70 | 25.68 | 25.01 | |
| Return on Assets (%) | 16.93 | 18.32 | 18.78 | 22.54 | 21.25 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 96.63 | 109.22 | 114.34 | 130.41 | 129.35 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.08 | 5.92 | 5.51 | 5.52 | 4.68 | |
| Quick Ratio (X) | 3.82 | 5.71 | 5.27 | 5.31 | 4.52 | |
| Inventory Turnover Ratio (X) | 23.16 | 41.89 | 38.42 | 51.47 | 54.34 | |
| Dividend Payout Ratio (NP) (%) | 57.21 | 27.81 | 18.68 | 23.97 | 16.12 | |
| Dividend Payout Ratio (CP) (%) | 43.85 | 23.46 | 15.77 | 20.42 | 12.84 | |
| Earnings Retention Ratio (%) | 42.79 | 72.19 | 81.32 | 76.03 | 83.88 | |
| Cash Earnings Retention Ratio (%) | 56.15 | 76.54 | 84.23 | 79.58 | 87.16 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 11,130.77 | 8,310.30 | 6,982.78 | 7,801.91 | 7,392.25 | |
| EV/Net Operating Revenue (X) | 8.74 | 7.13 | 6.82 | 8.85 | 9.66 | |
| EV/EBITDA (X) | 28.88 | 25.24 | 24.28 | 30.19 | 32.96 | |
| MarketCap/Net Operating Revenue (X) | 9.17 | 7.54 | 7.12 | 9.11 | 9.95 | |
| Retention Ratios (%) | 42.78 | 72.18 | 81.31 | 76.02 | 83.87 | |
| Price/BV (X) | 11.49 | 9.44 | 9.39 | 13.70 | 15.92 | |
| Price/Net Operating Revenue | 9.17 | 7.54 | 7.12 | 9.11 | 9.95 | |
| Earnings Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak